Experimental psychosis has a long history. It might have started with the administration of Cannabis indica boiling in wine to the ancient Hun warriors, resulting in mental obfuscation, as they were prepared for surgery because of wounds sustained in battle. Scientific experimental psychiatry began toward the end of the last century, in the Kraepelinian era—when the organic theory of psychoses was in its fullest vogue. Beringer's experiments with mescaline1 marked a milestone in research in that many of the symptoms induced were highly similar to those encountered in schizophrenia and the drug seemed to have had a selective affinity for the brain. The discovery of LSD-25* by Stoll and Hoffmann2 was an even more exciting event, because the drug worked similarly in infinitesimal-trace amounts. Stoll3 (1947) suggested the pharmacological designation Phantastium for this substance, and he classified the resultant model psychosis as that of the acute
BERCEL NA, TRAVIS LE, OLINGER LB, DREIKURS E, Polos MG. Model Psychoses Induced by LSD-25 in Normals: I. Psychophysiological Investigations, with Special Reference to the Mechanism of the Paranoid Reaction. AMA Arch NeurPsych. 1956;75(6):588–611. doi:10.1001/archneurpsyc.1956.02330240026003
Customize your JAMA Network experience by selecting one or more topics from the list below.